Company intelligence / Profile preview
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Nanjing, Jiangsu, China
- Ownership
- Private
- Employees
- ~1360
- Development stage
- Other
01
Overview
NKF is a leading biopharmaceutical enterprise with a strong focus on high-end injectables and heparin products. It has multiple ANDAs approved in the US and exports over 80 FDA-approved products globally.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Small moleculesHeparin APIsfinished dosage formsinjectables
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Partnerships with over 60 countriesrecent agreement with Meitheal Pharmaceuticals for biosimilars
Beyond the preview
Go deeper on Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd..